Soru

Zorluk: ZorDiagnostic Workup and Test Sequencing

During a comprehensive health evaluation, a physician palpates an asymmetric enlargement in the anterior neck of an asymptomatic 45-year-old software architect. The individual denies experiencing weight changes, heat intolerance, tremors, or difficulty swallowing. Vital signs show a heart rate of 82/min and a blood pressure of 124/78 mm Hg. Palpation of the neck reveals a firm, non-tender, mobile 2.2-cm2.2\text{-cm} nodule in the right thyroid lobe. There is no palpable cervical lymphadenopathy. Initial laboratory evaluation demonstrates a suppressed thyroid-stimulating hormone (TSH) concentration of 0.02 mU/L0.02 \text{ mU/L} (normal: 0.4−4.0 mU/L0.4-4.0 \text{ mU/L}) and an elevated free thyroxine (T4) concentration of 2.3 ng/dL2.3 \text{ ng/dL} (normal: 0.9−1.7 ng/dL0.9-1.7 \text{ ng/dL}). Dedicated ultrasonography of the neck confirms a 2.4-cm2.4\text{-cm} solid, hypoechoic nodule in the right lobe lacking high-risk features such as microcalcifications or irregular margins. Which of the following represents the most appropriate next step in the diagnostic sequence for this individual?

  1. A
    Computed tomography of the neck with intravenous contrast
  2. B
    Fine-needle aspiration biopsy of the nodule
  3. Radionuclide thyroid scintigraphyCevap
  4. D
    Measurement of thyroid-stimulating immunoglobulins
  5. E
    Routine follow-up ultrasonography in 12 months

Cevap

The most appropriate next step in the diagnostic sequence is to perform radionuclide thyroid scintigraphy.
The correct answer is radionuclide thyroid scintigraphy. In the evaluation of a newly discovered thyroid nodule with a concomitantly suppressed TSH, a radionuclide scan is the next indicated diagnostic step. It determines whether the nodule is hyperfunctioning ('hot') or nonfunctioning ('cold'). Hyperfunctioning nodules have a very low risk of malignancy and typically do not require cytological evaluation, whereas nonfunctioning nodules meeting size and sonographic criteria would require a fine-needle aspiration.

Adım Adım Çözüm

1
Analyze the patient's clinical presentation and initial laboratory findings.
The patient has an asymptomatic 2.4-cm thyroid nodule with laboratory evidence of primary hyperthyroidism, demonstrated by a suppressed TSH and an elevated free T4.
Initial evaluation of any thyroid nodule requires concurrent assessment of thyroid function via TSH measurement to establish the appropriate diagnostic pathway.
2
Apply diagnostic algorithms for thyroid nodules based on the initial TSH level.
Guidelines mandate that a subnormal TSH in the presence of a thyroid nodule requires functional assessment via a radionuclide scan (e.g., iodine-123 or technetium-99m).
A suppressed TSH indicates autonomous hormone production. Scintigraphy accurately differentiates a hyperfunctioning ('hot') nodule from a nonfunctioning ('cold') nodule within a hyperthyroid gland.
3
Determine the necessity of immediate cytological evaluation (biopsy).
A biopsy is deferred at this step because hyperfunctioning nodules rarely harbor malignancy and typically do not require fine-needle aspiration.
Performing scintigraphy first prevents the sequencing error of unnecessarily biopsying a benign, toxic adenoma, thereby minimizing patient risk.

Anahtar Kavram

In patients presenting with a newly discovered thyroid nodule and a concomitantly suppressed TSH, radionuclide thyroid scintigraphy is the essential next step to determine the functional status of the nodule and the subsequent need for cytological evaluation.
Bu soruyu puanla